t-cells

Documents about t-cells

• A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia#405159ClinicalTrials.gov
• Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia#411380ClinicalTrials.gov
• ACSL5 programs fatty acid metabolism and mitochondrial fitness to sustain pathogenic T cells and exacerbate Sjögren's syndrome.#412268NCBI PubMed Central
• Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients#451481ClinicalTrials.gov
• CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor#481751ClinicalTrials.gov
• Identification of pre-existing ubiquitous neoantigen-reactive tumor-infiltrating T-cells in a patient with metastatic pancreatic neuroendocrine tumor#633101bioRxiv / medRxiv
• Uridine and pyruvate supplementation is associated with Th1 polarization during mitotoxic antibiotic therapy#676410Europe PMC
• Identification of Hepatitis C Virus (HCV) Specific T Cells#812757ClinicalTrials.gov
• CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies#846096ClinicalTrials.gov
• CAR-T Cells Therapy for Patients With Autoimmune Diseases#849048ClinicalTrials.gov
• Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)#852287ClinicalTrials.gov
• A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy#856066ClinicalTrials.gov
• Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer#873371ClinicalTrials.gov
• TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors#895122ClinicalTrials.gov
• Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine#910764ClinicalTrials.gov
• Allogeneic γδT Cells in Glioblastoma#912960ClinicalTrials.gov
• Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma#915975ClinicalTrials.gov
• A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas#856853ClinicalTrials.gov
• Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma#857900ClinicalTrials.gov
• Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T#881864ClinicalTrials.gov
• Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients#908432ClinicalTrials.gov
• FIBROBLAST ACTIVATION PROTEIN+ STROMAL CELLS PROMOTE MACROPHAGE-MEDIATED IMMUNOSUPPRESSION AND LIMIT CAR-T CELL ACCUMULATION IN GLIOBLASTOMA#929313ScholarlyCommons
• Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease#876810ClinicalTrials.gov
• The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies#903443ClinicalTrials.gov
• A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients#913739ClinicalTrials.gov
• The dynamics of glycosylation in trophoblast cells: development, function, and pregnancy-related disorders#4569Europe PMC
• TRPV1 from the TRP family: Structure, function, implication in autoimmune diseases and potential therapies#4713Europe PMC
• COX-2 regulates IL-17A-producing γδ T cells to drive mismatch repair-deficient colon cancer#130497Unpaywall
• Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study#143674ClinicalTrials.gov
• CD31+ T-cells express greater VEGF-A and CXCR4 levels than CD31- counterparts with VEGF-A expression exacerbated with advancing age#146494bioRxiv / medRxiv
• A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM#152575ClinicalTrials.gov
• CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS#160346ClinicalTrials.gov
• CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers#180378ClinicalTrials.gov
• CRISPR-mediated functional mapping of IL2RG variants in primary human T cells predicts X-linked severe combined immunodeficiency#234335bioRxiv / medRxiv
• CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis#273159Europe PMC
• Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer#279563ClinicalTrials.gov
• GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma#303733ClinicalTrials.gov
• Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes#395363HAL (France)
• Immunopathogenesis of severe pneumonia in children with emphasis on CD4+ T cells, Tim-3 and cytokine-mediated immune dysregulation.#418427NCBI PubMed Central
• IL-7Rαlow CD8+ T Cells from Healthy Individuals Are Anergic with Defective Glycolysis#439893S-Space: Seoul National University
• Role of extracellular vesicles in allergic sensitization#466528University of Nottingham Repository
• Warfarin affects acute inflammatory response induced by subcutaneous polyvinyl sponge implantation in rats#643948IBISS
• Extinction-restraint intervention eradicates fear memory encoded in BLA engram cells via D2 receptor-mediated dopaminergic modulation from locus coeruleus.#645214NCBI PubMed Central
• Large airway T cells in adults with former bronchopulmonary dysplasia#654746Research Online
• A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)#801249ClinicalTrials.gov
• Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors#830965ClinicalTrials.gov
• Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant#859804ClinicalTrials.gov
• The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis#866964ClinicalTrials.gov
• EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma#885649ClinicalTrials.gov
• Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.#888940ClinicalTrials.gov